Friday, October 06, 2017 9:19:50 AM
MarketNewsUpdates.com News Commentary
PALM BEACH, Florida, October 6, 2017 /PRNewswire/ --
Oppenheimer's Leah Rush Cann recently published an article on Barron's writing Biotech stocks, that still remain sharply undervalued, with an optimistic outlook that comes on the heels of the biotech sector has posted a 17.7% gain this year through September. Her opinion is that the sector is showing 'increasing strength'. The biotech rally appears to be far from over as clinical trials advance, FDA Approvals are happening quicker and new collaborations leading to multiple therapeutic benefits are taking hold.
http://www.otcmarkets.com/stock/TWMJF/news
RSII may not be listed in this article today.........but you can bet it will be soon;
RSII is a Biotech Pharmaceutical Company specializing in the development of Alternative Pain Medications. The world needs to STOP using so many OPIODS.
$$$RSII$$$
VAYK Discloses Strategic Conversation on Potential Acquisition of $4 Million Home Service Business • VAYK • May 9, 2024 9:00 AM
Bantec's Howco Awarded $4.19 Million Dollar U.S. Department of Defense Contract • BANT • May 8, 2024 10:00 AM
Element79 Gold Corp Successfully Closes Maverick Springs Option Agreement • ELEM • May 8, 2024 9:05 AM
Kona Gold Beverages, Inc. Achieves April Revenues Exceeding $586,000 • KGKG • May 8, 2024 8:30 AM
Epazz plans to spin off Galaxy Batteries Inc. • EPAZ • May 8, 2024 7:05 AM
Moon Equity Holdings, Corp. Announces Acquisition of Wikolo, Inc. • MONI • May 7, 2024 9:48 AM